Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, August 9 '25)

Image
By G.M.

 


    Ann Intern Med

  1. CONLY J
    Expression of Concern: Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers.
    Ann Intern Med. 2025 Aug 5. doi: 10.7326/ANNALS-25-03203.
    PubMed        

  2. BADUASHVILI A, Radonovich L, Leslie L, Pease S, et al
    Engineering Infection Controls to Reduce Indoor Transmission of Respiratory Infections : A Scoping Review.
    Ann Intern Med. 2025 Aug 5. doi: 10.7326/ANNALS-25-00577.
    PubMed         Abstract available


    Antiviral Res

  3. YAO G, Shi X, Jiang H, Duan A, et al
    Design, synthesis, and biological evaluation of novel 6-aminoalkyl- and 7-heteroaryl substituted 7-deazapurine nucleoside analogs against SARS-CoV-2 Replication.
    Antiviral Res. 2025 Aug 1:106246. doi: 10.1016/j.antiviral.2025.106246.
    PubMed         Abstract available


    Clin Infect Dis

  4. BHIMRAJ A, Falck-Ytter Y, Baden LR, Bedimo R, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Cri
    Clin Infect Dis. 2025 Aug 4:ciaf424. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  5. DAVIDO B, Loubet P
    The Silent Surge: The Underrecognized Burden of Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Viruses in Adults.
    Int J Infect Dis. 2025 Jul 31:108006. doi: 10.1016/j.ijid.2025.108006.
    PubMed         Abstract available


    J Med Virol

  6. PONCE LJ, Wang Y, Singh A, Chua HK, et al
    Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection.
    J Med Virol. 2025;97:e70521.
    PubMed         Abstract available

  7. COSTA PT, Mello LS, Marques LFA, Dos Santos VS, et al
    Vaccination Coverage Against Coronavirus Disease 2019 in People Living on Quilombos in Brazil and Its Association With the Human Development Index and the Quality of the Health System.
    J Med Virol. 2025;97:e70533.
    PubMed         Abstract available

  8. LI F, Zhao W, Liu H, Niu Y, et al
    Single-Cell Omics Analysis Reveals Immunological Dysregulation in COVID-19 and HIV: Identifying a Shared Abnormality of B Cell Activation via the Unfolded Protein Response and Diagnostic Biomarkers Using Machine Learning Algorithms.
    J Med Virol. 2025;97:e70538.
    PubMed         Abstract available

  9. LIANG P, Li C, Li Y, Xiong J, et al
    Causal Effects of Life-Course Adiposity and Metabolic Mediators on the Immune Response to COVID-19 Vaccination.
    J Med Virol. 2025;97:e70540.
    PubMed         Abstract available

  10. COSTA-FILHO RC, Oliveira A Jr, Saddy F, Costa JLF, et al
    Evaluating the Effectiveness of NOACs and LMWH in Reducing Mortality in Critically Ill Patients With COVID-19.
    J Med Virol. 2025;97:e70535.
    PubMed         Abstract available

  11. TREMEAUX P, Latour J, Vellas C, Demmou S, et al
    Performance of Long-Read Single-Molecule Real-Time Sequencing for SARS-CoV-2 Genotyping in Clinical Samples.
    J Med Virol. 2025;97:e70539.
    PubMed         Abstract available

  12. DUWE S, Oh DY, Wedde M, Bornigen D, et al
    Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021-2023, and Characterization of Newly Emerged Virus Clades.
    J Med Virol. 2025;97:e70530.
    PubMed         Abstract available


    J Virol

  13. SOWNTHIRARAJAN B, Mason M, Loganathan G, Manivasagam S, et al
    A versatile H5N1-VSV platform for safe influenza virus research applications.
    J Virol. 2025 Aug 8:e0097525. doi: 10.1128/jvi.00975.
    PubMed         Abstract available

  14. MA Y, Ye C, Khalil AM, Mahmoud SH, et al
    A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
    J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
    PubMed         Abstract available

  15. YU R, Bai Y, Zhang L, Zhou P, et al
    Single self-cleaving mRNA vaccine expressing multiple viral structural proteins elicits robust immune responses and protects nursing piglets against PDCoV infection.
    J Virol. 2025 Aug 6:e0084925. doi: 10.1128/jvi.00849.
    PubMed         Abstract available


    JAMA

  16. ANDERER S
    Booster Shots Help Prevent Severe COVID-19 in People With Cancer.
    JAMA. 2025 Aug 8. doi: 10.1001/jama.2025.10996.
    PubMed        


    Lancet Infect Dis

  17. HANSEN CH, Lassauniere R, Rasmussen M, Moustsen-Helms IR, et al
    Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted vaccines against COVID-19-associated hospitalisation and death: a Danish, nationwide, register-based, cohort study.
    Lancet Infect Dis. 2025 Jul 29:S1473-3099(25)00380.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  18. RODRIGUEZ RM, Torres JR, Chinnock B, Kean E, et al
    Emergency Department Survey of Vaccination Knowledge, Vaccination Coverage, and Willingness to Receive Vaccines in an Emergency Department Among Underserved Populations - Eight U.S. Cities, April-December, 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:456-462.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  19. MA N, Zhou BJ, Zhang JY, Gao J, et al
    [Clinical analysis of thirteen cases of pulmonary infection caused by Nocardia otitidiscaviarum].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:732-737.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »